Drugs and biologicals

Ended Awarded

Contract number
HHSN26300259
Awardee
Awarding agency
Obligated
$8,709

Award facts

Contract value 100% obligated
$8,709.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Billerica, MA 01821, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institutes of Health (NIH) to EMD Millipore Corp, a foreign-owned, for-profit manufacturer of laboratory products and services. The $8,709 award is for the delivery of drugs and biologicals with a period of performance ending on December 31, 2015. EMD Millipore Corp, doing business as Milliporesigma, is a subsidiary of Merck KGaA and has established itself as a critical supplier of laboratory technologies and consumables to numerous U.S. government research and testing institutions. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract HHSN26300259?

HHSN26300259 was awarded to EMD Millipore Corp by Office of the Director (National Institutes of Health) on March 20, 2015.

How much is contract HHSN26300259 worth?

The government has obligated $8,709 on HHSN26300259.

Is contract HHSN26300259 an order under another contract?

Yes. HHSN26300259 is a BPA call under HHSN263199900051144B, a blanket purchase agreement.

Was contract HHSN26300259 competed?

The extent of competition for HHSN26300259 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award